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Background.  Variable adherence to standardized case definitions, clinical procedures, specimen collection techniques, and lab-
oratory methods has complicated the interpretation of previous multicenter pneumonia etiology studies. To circumvent these prob-
lems, a program of clinical standardization was embedded in the Pneumonia Etiology Research for Child Health (PERCH) study.
Methods. Between March 2011 and August 2013, standardized training on the PERCH case definition, clinical procedures, 
and collection of laboratory specimens was delivered to 331 clinical staff at 9 study sites in 7 countries (The Gambia, Kenya, Mali, 
South Africa, Zambia, Thailand, and Bangladesh), through 32 on-site courses and a training website. Staff competency was assessed 
throughout 24 months of enrollment with multiple-choice question (MCQ) examinations, a video quiz, and checklist evaluations of 
practical skills.
Results. MCQ evaluation was confined to 158 clinical staff members who enrolled PERCH cases and controls, with scores 
obtained for >86% of eligible staff at each time-point. Median scores after baseline training were ≥80%, and improved by 10 per-
centage points with refresher training, with no significant intersite differences. Percentage agreement with the clinical trainer on the 
presence or absence of clinical signs on video clips was high (≥89%), with interobserver concordance being substantial to high (AC1 
statistic, 0.62–0.82) for 5 of 6 signs assessed. Staff attained median scores of >90% in checklist evaluations of practical skills.
Conclusions. Satisfactory clinical standardization was achieved within and across all PERCH sites, providing reassurance that any 
etiological or clinical differences observed across the study sites are true differences, and not attributable to differences in application 
of the clinical case definition, interpretation of clinical signs, or in techniques used for clinical measurements or specimen collection.
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Current pneumonia treatment and prevention strategies are 
based mainly on data obtained from large clinical studies car-
ried out in the 1980s. One such study, sponsored by the Board 
of Science and Technology for International Development 
(BOSTID), National Academy of Sciences, yielded valu-
able information on the pathogens present during acute 
respiratory infections (ARIs) in children <5  years old from 
resource-limited countries [1]. However, interpretation of 
the wide range of reported ARI incidence rates was compli-
cated in part by the lack of a standardized case definition at 
the 10 participating study sites [2]. A  subsequent literature 
review of pneumonia etiology studies, conducted between 
2000 and 2010 on children aged <5 years, revealed wide dis-
parity in case definitions, specimen collection techniques, 
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and laboratory methods, which increased the complexity of 
data collation and analysis [3]. Other studies have demon-
strated substantial interclinician variation in the interpreta-
tion of clinical signs of severe disease in children and young 
infants [4–7]. Standardization of the clinical [8], radiological 
[9], laboratory [10], and data management methods [11] at 
all PERCH sites has been prioritized since inception, as we 
wished to ensure that any observed variation in pneumonia 
etiology between sites was not attributable to methodological 
differences. The objectives of the clinical standardization pro-
gram were to ensure that study staff (1) adhered strictly to the 
clinical case definitions; (2) were consistent in their assess-
ment, recognition, and interpretation of clinical signs; (3) 
used standardized equipment and techniques for obtaining 
clinical measurements; and (4) used standardized methods 
for obtaining key clinical samples for laboratory testing. This 
paper describes the PERCH clinical standardization program 
of clinical training, retraining, and staff assessment that ran 
throughout the study.
METHODS
Study Sites
At all sites (Table  1), clinical assessment and enrollment of 
PERCH cases and controls were carried out by doctors, nurses, 
and clinical officers (health workers with at least 3  years of 
formal clinical training). Nurses and field workers or research 
assistants took anthropometric measurements, assisted clinical 
staff with procedures, and identified and located PERCH com-
munity controls.
Preparatory Phase
The PERCH case definition (Table  2) was based on the 
2005 World Health Organization (WHO) clinical defin-
ition of severe and very severe pneumonia [8]. The defin-
ition relies on the presence of prespecified clinical signs, 
without information from chest radiograph (CXR) or pulse 
oximetry. The PERCH enrollment period predated the 2013 
reclassification of severe and very severe pneumonia by the 
WHO [12].
Through a series of teleconferences and 2 face-to-face 
meetings between all PERCH principal investigators (PIs), 
consensus was achieved on how to elicit, recognize, and 
interpret each of the signs and symptoms comprising the 
PERCH clinical case definition (Table 2), and on the choice 
of methods and equipment for obtaining key clinical meas-
urements (pulse oximetry, anthropometry, respiratory rate) 
and clinical samples (nasopharyngeal [NP] and oropharyn-
geal [OP] swabs, induced sputum [IS], lung aspirates, blood, 
urine).
Training materials and advice were sought from a wide 
variety of sources (see Acknowledgments). Many of the 
clinical video clips, audio recordings and photographs were 
recorded at PERCH sites by the principal trainer (J. C.), 
with written informed consent from the patient’s parents or 
guardians.
Table 1. Profile of Pneumonia Etiology Research for Child Health (PERCH) Study Sites
Country Training Language Study Site Setting Start of Enrollment
Staff Responsible for Enrollment of 
PERCH Cases and/or Controls
Cadre No. (%) Total
Kenya English Kilifi Rural August 2011 Doctor 3 (13) 23
COa 18 (78)
Nurse 2 (9)
South Africa English Johannesburg Urban August 2011 Doctor 1 (8) 13
Nurse 12 (92)
Zambia English Lusaka Urban October 2011 Doctor 4 (23) 17
COa 3 (18)
Nurse 10 (59)
The Gambia English Basse Rural November 2011 Doctor 7 (23) 31
Nurse 24 (77)
Mali Frenchc Bamako Urban January 2012 Doctor 12 (67) 18
Nurse 6 (33)
Bangladesh Banglac & 
English
Dhaka Urban January 2012 Doctorb 37 (100) 37
Matlab Rural January 2012
Thailand Thaic & 
English
Sa Kaeo Mixed January 2012 Doctor
Nurse
2 (11)
17 (89)
19
Nakhon 
Phanom
Mixed February 2012
Total 158
Abbreviations: CO, clinical officer; PERCH, Pneumonia Etiology Research for Child Health.
aClinical officers are health workers with at least 3 years of formal clinical training.
bIn Bangladesh, all enrollment decisions were made by doctors, although nurses helped to identify potential cases and controls.
cMultiple-choice questions (MCQs) were translated into French (Mali) or Thai (Thailand); staff in Bangladesh took MCQs in English.
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Training Courses
Initial clinical standardization training occurred at all sites 
immediately prior to a period of pilot enrollment. All sites 
enrolled to the main study for 24 months, with refresher train-
ing carried out in the first and second year.
The initial 3-day training and subsequent 2-day refresher 
training courses were conducted at all sites by the principal 
trainer, with support from site project leaders. All cadres of 
PERCH staff (doctors, nurses, clinical officers, research assis-
tants, and field workers) were trained together; interested local 
non-PERCH clinicians were invited to participate.
Training courses comprised lectures, discussion of case 
scenarios in small groups, practical sessions, and ward-based 
clinical teaching. The initial training lectures covered the back-
ground to the PERCH study, rationale for clinical standardiza-
tion, recognition of the critically ill child, clinical assessment 
of the child with cough or difficulty breathing, vital signs, 
pulse oximetry, techniques for collection of NP/OP swabs, and 
anthropometry. Discussion of PERCH case scenarios, designed 
to test the trainees’ ability to identify signs and symptoms that 
constitute study inclusion and exclusion criteria, took place in 
groups of 8–10 people, each group being led by the principal 
trainer and/or a local facilitator. Trainees were divided into 
groups of 5–8 for hands-on instruction in clinical assessment. 
Staff members were asked to conduct clinical assessments on 
children, and were assessed on their ability to elicit and cor-
rectly interpret clinical signs.
Practical skills were taught through training videos, demon-
strations, and hands-on practice in small groups, with key points 
highlighted in summary lectures. Clinically stable children acted 
as subjects for the anthropometry training. Staff learned NP/OP 
swab collection by practicing on each other. Clinicians from sites 
where IS samples were routinely collected from children (Kenya, 
The Gambia, South Africa) trained staff from the other 4 sites. The 
clinical team in Kenya reviewed video recordings of the collec-
tion procedures in The Gambia and South Africa, to ensure that 
they were consistent with procedures in Kenya. IS training was 
included in the refresher courses, as was guidance on reducing 
blood culture contamination rates through improved phlebot-
omy technique. Ethical approval to perform diagnostic percu-
taneous needle lung aspiration among PERCH cases was only 
obtained in The Gambia, Mali, South Africa, and Bangladesh. 
Clinicians from The Gambia (where lung aspiration is performed 
frequently on children with focal consolidation on CXR [13]) 
trained PERCH staff from the other 3 countries. Pleural aspirates 
and gastric aspirates were not included in the training as they 
were not designated PERCH procedures, but were carried out as 
routine hospital procedures if clinically indicated.
Table 2. Pneumonia Etiology Research for Child Health (PERCH) Clinical Case Definition of Severe and Very Severe Pneumoniaa
Case Sign or Symptom Detailed Definition
Pneumonia (nonsevere) Cough or difficulty breathing plus fast breathing
Cough On history and/or examination
Difficulty breathing Fast, labored, deep, irregular, or noisy breathing
Fast breathing Respiratory rate (breaths/min): ≥60 (<2 mo); ≥50 (2–11 mo); ≥40 (1–5 y)
Severe pneumonia Cough or difficulty breathing plus lower chest wall indrawing
Lower chest wall 
indrawing
Inward movement of the lower bony chest wall on inspiration; child must be calm and not 
crying
Very severe pneumonia Cough or difficulty breathing plus any of the following signs or symptomsb:
Central cyanosis Blue discoloration of lips, gums, and tongue; should be assessed under good lighting 
conditions
Head nodding Flexion of the head with inspiration; more commonly seen in young children and infants. 
Most easily seen if child is upright
Unable to drink or 
breastfeed
This must be observed in the clinical environment, by study staff:
<2 mo: feeding poorly (eg, poor attachment to breast, weak suck)
≥2 mo: inability to take anything (fluids or solids) by mouth
Vomiting everything This must be observed in the clinical environment, by study staff:
Child is given a drink: if child has not vomited by the end of the clinical assessment, and 
before study procedures are carried out, then s/he is not “vomiting everything”
Lethargy or 
unconsciousness
AVPU scorec = V, P, or U
Convulsions this illness Based on detailed description by parent or guardian. For inclusion in PERCH, convulsions 
must be prolonged (≥15 min) or multiple (≥2 within a 24-h period during the current illness)d
Abbreviation: PERCH, Pneumonia Etiology Research for Child Health.
aBased on World Health Organization (2005) clinical case definition of severe and very severe pneumonia (Pocket Book of Hospital Care for Children).
bLower chest wall indrawing is not a defining sign of very severe pneumonia as it may disappear if the child becomes exhausted.
cAVPU score: (1) clinician first assesses whether the child is alert; A = alert (child takes an age-appropriate interest in their environment); if child not alert, clinician tests, in sequence, V, 
P, and U, stopping when the child gives a positive response; (2) clinician calls the child’s name without simultaneously touching him or her; V = response to voice (any consistent visual, 
verbal, or motor response to voice); (3) clinician presses on the base of the child’s fingernail using a pencil or pen; P = response to pain (child withdraws digit); (4) U = unresponsive or 
unconscious (no response to pain).
dDefinition of complex febrile seizure used by American Academy of Pediatrics (Pediatrics 2011; 127: 389–94); PERCH adopted a stringent definition of “convulsions this illness” to avoid 
enrolling large numbers of children with cough and simple febrile seizures.
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All courses finished with a multiple-choice question (MCQ) 
examination, presentation of certificates, prizes for those 
achieving top scores, and a group photograph. All participants 
were invited to provide feedback, using a Likert scale to grade 
the quality of different course components.
Clinical Standardization Guidelines
Guidelines summarizing key information from the training 
program were distributed to all staff at the time of refresher 
training, with an electronic version made available on the inter-
nal PERCH study website.
Training Website
A training website (www.perchtraining.org), developed in asso-
ciation with a company specializing in digital healthcare (see 
Acknowledgments), had the following objectives: (1) to act as 
a repository for the clinical standardization training materials, 
thereby supporting the training of any new staff who had missed 
their initial site training course; (2) to provide continuing train-
ing of all PERCH staff throughout study enrollment; and (3) 
to facilitate regular evaluation of all PERCH clinical staff, and 
comparison of staff performance within and across sites.
The website contained all lectures from the initial training 
course, which could be streamed or downloaded as lectures 
with recorded voice-over, or as PowerPoint presentations. When 
internet speeds were slow, staff accessed training materials from 
DVDs, which had been distributed to all sites at the start of the 
study. At several sites, limited access to personal computers 
meant that project leaders downloaded the MCQs and organ-
ized the evaluations as classroom sessions. The website baseline 
training was supplemented by on-site training in practical skills 
and ward-based clinical teaching, both coordinated by the local 
PERCH study leader. On completion of the online course, train-
ees were required to take the same MCQ examination as those 
who had participated in face-to-face training. Trainees achiev-
ing a score of 80% or more were able to download a certificate 
from the website. The website also contained 2 additional MCQ 
examinations and a video quiz (see Evaluation).
Evaluation
MCQ examinations were conducted after initial baseline train-
ing, immediately before and after each refresher course, and 
online after 10 months and 20 months of enrollment. An online 
video quiz was used to assess interobserver variation in inter-
pretation of clinical signs at 20 months. Checklist evaluation of 
practical skills was performed at the end of the first year.
MCQs were designed to test knowledge and understand-
ing of the screening, consent and enrollment process, and the 
recognition and correct interpretation of key clinical signs, 
particularly those included in the WHO definitions of severe 
and very severe pneumonia. Each of the 10–20 MCQs con-
tained a typical PERCH case scenario, plus, in most cases, a 
photograph or short video of a clinical sign. Answers to each 
question were provided at the end of the quiz, once all of the 
questions had been answered, with explanatory notes high-
lighting key learning points. Staff scoring <80% in the MCQ 
administered after baseline training were required to repeat 
selected lectures and the quiz, while staff scoring <80% after 
refresher training received additional training from their 
site-specific trainer.
The video quiz assessed the ability of clinical staff to identify 
6 clinical signs (lower chest wall indrawing [LCWI], head nod-
ding, deep breathing, central cyanosis, nasal flaring, alert child). 
Clinical staff were shown 35 video clips (10 videos of LCWI, 
the defining clinical feature of WHO severe pneumonia, and 
5 videos of each of the other clinical signs). Each video lasted 
approximately 10 seconds, and clinicians had to decide whether 
a specific clinical sign was present or not.
Local clinical standardization trainers observed PERCH 
nurses and field workers carrying out anthropometry, IS, and 
NP/OP swab collection. Scored checklists (Supplementary 
Tables 1–3) were used to award points for key predefined proce-
dural steps, the resulting percentage score providing a measure 
of procedural competence.
Statistical Analysis
Median percentage scores and interquartile range (IQR) were 
calculated for MCQ tests and checklists. Median MCQ scores 
before and after refresher training were compared using the 
Wilcoxon signed-rank test. The distribution of results across 
participants was compared within and across study sites. Results 
were stratified by professional cadre and by whether staff 
assessed both cases and controls, or controls only. Differences 
between groups were examined with the Kruskal-Wallis test.
For each of the 6 clinical signs in the video quiz (35 videos in 
total), individual responses were used to assess the percentage 
agreement between the clinical staff and the principal trainer, 
who was the designated “gold standard.” Calculation of Fleiss’ κ 
and the Gwet AC1 statistic, which is less affected by low prev-
alence than the κ statistic, were used to measure the degree of 
interobserver variability [14–16].
Kaplan-Meier curves were constructed to illustrate the pro-
portion of PERCH clinical staff remaining in the study, from the 
time of baseline clinical standardization training. Curves were 
censored when staff members left the study, or on completion 
of PERCH enrollment.
RESULTS
Training Courses
Between March 2011 and August 2013, a total of 32 training 
courses were conducted at 8 study sites in 7 countries. Of 331 
staff attending 1 or more courses, 45 (14%) were interested local 
clinical staff, not directly involved in the study. Feedback from 
course participants was positive, with 90% of all course com-
ponents being graded as “very good” (4/5) or “excellent” (5/5).
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Initial (baseline) clinical standardization training took 
place over a 6-month period between March and September 
2011. At each site, training occurred immediately prior to a 
period of pilot enrollment, and a median of 5 months (range, 
4–9 months) before the start of the study. Seventy staff members 
joined PERCH after the initial training course at their site, and 
received baseline training from their site project leader and/
or the training website. In South Africa, baseline training was 
repeated 6 months after the start of enrollment, due to extensive 
staff turnover during the pilot period.
The first round of refresher training took place a median 
of 7 (range, 5–11) months and the second round a median of 
18 months (range, 14–21) after the start of the study. A national 
nurses strike in Kenya during 2012 delayed refresher training by 
3 months. At all other sites, training and enrollment continued 
uninterrupted, despite extensive flooding in Thailand during 
2011, civil war in Mali during 2012–2013, and political instabil-
ity in Bangladesh during 2013.
Evaluation
MCQ and video quiz results are presented for the 158 doc-
tors, clinical officers, and nurses who enrolled PERCH cases 
and/or controls. High rates of staff turnover meant that only 
57 of 158 (36.1%) of those who received baseline training 
completed all 7 MCQs plus the video quiz, but at each eval-
uation time-point MCQ scores were available for a median 
of 94% (IQR, 87%–100%) of the eligible staff at all sites 
(Table 3). Median scores were ≥80% at each point of testing, 
and improved with refresher training by a median of 10 per-
centage points. There was significant heterogeneity (P < .001) 
in the range of baseline training scores between sites, with 
South Africa and Mali having the greatest range of scores and 
Thailand the least variability (Figure  1A). Refresher train-
ing scores are shown in Figure  1B and 1C. The proportion 
of staff attaining a score of ≥80% rose from 54.7% and 60.4% 
before refresher training 1 and 2, respectively, to 84.9% and 
82.8% after training (Table  3). The difference between pre- 
and postcourse scores (excluding those attaining 100% in the 
precourse MCQ) did not vary significantly (P > .8) between 
sites. Median precourse MCQ scores were significantly lower 
among nurses and clinical officers compared to doctors 
(Table  4); nurses who assessed controls only scored lower 
than those who assessed both cases and controls, though 
(with the exception of prerefresher training 1)  this failed to 
reach statistical significance.
Checklist evaluations of practical skills were carried out on 
105 of 166 (63%) staff performing NP/OP swabs, 64 of 112 
(57%) staff collecting IS samples, and 107 of 166 (64%) staff 
conducting anthropometry. Analyzing all sites combined, 
median checklist scores were 92% (IQR, 90%–96) for NP/OP 
swabs, 96% (IQR, 90%–98) for IS, and 95% (IQR, 88%–100) for 
anthropometry, with a median score of >82% for each of the 3 
skills when analyzing by site.
The video quiz took place during the final 4 months of enroll-
ment at each site. Ninety-six of 110 current staff members par-
ticipated, of whom 42 (44%) were nurses, 40 (42%) doctors, 
and 14 (14%) clinical officers. Percentage agreement between 
participants and the clinical trainer was high (≥89%) for all 
clinical signs (Table  5). Interobserver concordance was mod-
erate for central cyanosis (AC1 statistic, 0.54); substantial for 
LCWI, deep breathing, nasal flaring, and the alert child (AC1, 
0.62–0.82); and excellent for head nodding (AC1, 0.88).
Table 3. Multiple-Choice Question Scores for Clinical Staff Assessing Pneumonia Etiology Research for Child Health (PERCH) Cases and/or Controls, by 
Evaluation Time-Point (All Study Sites)
Evaluation (MCQ)
Time-Point
No. of Clinical 
Staffa
No. of Staff With 
MCQ Scoreb
MCQ Score Improvement With Refresher Trainingc
Median % Score 
(IQR)
Percentage Scoring 
≥80
Median Difference (Post- 
Pre) (IQR)
Percentage With 
Improved Scores
Postbaseline trainingd 158 144 100 (90–100) 87.5
Prerefresher training 1 110 95 80 (65–90) 54.7 10 (10–20)e 93.1
Postrefresher training 1 110 99 90 (85–100) 84.9
Online MCQ 1 110 103 90 (80–100)f 90.3
Prerefresher training 2 105 96 80 (70–90) 60.4 10 (5–15)e 88.5
Postrefresher training 2 105 93 90 (80–100) 82.8
Online MCQ 2 110 99 90 (75–100)f 74.8
Abbreviations: IQR, interquartile range; MCQ, multiple-choice question; PERCH, Pneumonia Etiology Research for Child Health.
aThe reduction in staff numbers after baseline training reflects staff loss, which was greatest during the pilot period and early months of recruitment.
bMissing values: (i) Baseline training (n = 14): All 14 staff received baseline training; 9 joined PERCH during the last 6 months of recruitment and trained online, but failed to take the final 
MCQ; 2 were site trainers, 1 of whom had translated all of the MCQ questions, answers, and explanations into Thai; 3 MCQ scores were mislaid. (ii) Refresher training (median, 11 [range, 
7–15]): staff absent from refresher training 1 or 2 or the online MCQs were on sick, compassionate, annual, or maternity leave, or were carrying out essential ward duties.
cExcludes staff scoring 100% on the prerefresher training.
dBaseline training refers to the training that all staff underwent at the time of joining the study; it does not relate to a specific time-point, as new staff members were recruited throughout 
the study.
eP < .001 with Wilcoxon signed-rank test.
fP = .17 with Kruskal-Wallis test (no significant difference in distribution of scores between online MCQ1 and MCQ2).
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Staff Retention
Figure 2 provides an intersite comparison of staff retention for 
137 staff members who attended the initial training course at 
their site, prior to the start of study enrollment. Retention varied 
by site (log-rank test for equality of survivor function across 
sites: P < .001) and cadre, with retention of clinical officers (86% 
[18/21] of whom were at the Kenya site) being significantly 
higher than retention of nurses and doctors (log-rank test, P = 
Figure 1. Distribution of multiple choice question (MCQ) scores by site and training time-point: postbaseline training (A), pre- and postrefresher training 1 (B), and refresher 
training 2 (C). Boxplots display the distribution of MCQ scores. The number beneath each boxplot indicates the number of Pneumonia Etiology Research for Child Health 
(PERCH) clinicians and nurses who took the MCQ at each site. The diamond and horizontal line within the boxes represent the mean and median, respectively. The box reflects 
the interquartile range (IQR) and the whiskers extend to 1.5 multiplied by the IQR in either direction, or maximum and minimum values (if no outliers). The circle indicates 
outliers (values lying outside 1.5 multiplied by the IQR). Abbreviations: BAN, Bangladesh; GAM, The Gambia; KEN, Kenya; MAL, Mali; MCQ, multiple-choice question; pre, 
pre-course MCQ; post, post-course MCQ; RF1, refresher training 1; RF2, refresher training 2; SAF, South Africa; THA, Thailand; ZAM, Zambia.
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.016). Retention over 24 months of enrollment was high (>80%) 
in Kenya and Mali; moderate (40%–70%) in Bangladesh, 
Thailand, Zambia, and The Gambia; and low (<30%) in South 
Africa.
DISCUSSION
Although staff training is an important component of all clini-
cal trials, most studies fail to document its content or evaluate 
and report on its effectiveness [17]. By means of MCQs, a video 
quiz, and checklist evaluation of practical skills, we assessed key 
knowledge and clinical skills of PERCH staff throughout the 
duration of the study. Despite considerable challenges posed 
by staff turnover, language differences, intersite variation in the 
number and cadre of staff performing clinical assessments, and 
political and geographic factors beyond our control, a satisfac-
tory level of clinical standardization was achieved within and 
across all study sites. Because of clinical standardization, we 
consider that the variable proportion of very severe pneumonia 
cases at different PERCH sites, from 10% in Bangladesh, where 
screening took place in an outpatient clinic, to approximately 
50% among hospitalized children in Mali and Kenya, is a true 
reflection of intersite differences in case severity.
MCQs were administered at the end of baseline training and 
at regular intervals throughout the study. To answer questions 
correctly, staff needed thorough knowledge of the PERCH case 
definition and inclusion and exclusion criteria, and the ability to 
recognize and interpret key clinical signs from the accompany-
ing video clips. The lower MCQ scores attained in Mali follow-
ing baseline training may have been because the 3-day course 
concluded 1  day early due to extenuating circumstances, and 
was delivered in French by a nonnative speaker. In Thailand and 
Bangladesh, courses were delivered in both English and Thai or 
Bangla, and MCQ scores at these sites were comparable to the 
scores from countries where English is more widely spoken. At 
all sites and time points, doctors attained significantly higher 
MCQ scores than clinical officers and nurses, who generally 
spend a shorter period of time in professional clinical training. 
The nurses who only assessed healthy controls scored worse 
than nurses assessing both cases and controls, probably because 
they were exposed to fewer children with clinical signs.
Table 4. Multiple-Choice Question Scores by Cadre and Role
Evaluation Time-Point
MCQ % Score,
Median (IQR)
MCQ % Score,
Median (IQR)
Doctor Clinical Officer Nurse
Nurses
Sees Cases and 
Controls
Nurses
Sees Controls 
Only
No. No. No. P Valuea No. No. P Valuea
Postbaseline training 64 100 (90–100) 16 100 (90–100) 64 90 (80–100) .07 49 90 (90–100) 15 90 (70–100) .10
Prerefresher training 1 42 85 (75–90) 13 75 (60–85) 40 75 (62.5–85) .02 31 80 (65–95) 9 65 (55–65) .02
Postrefresher training 1 44 95 (90–100) 13 90 (80–95) 42 90 (75–100) .05 32 90 (80–100) 10 77.5 (65–90) .08
Online MCQ 1 46 100 (90–100) 17 90 (80–90) 40 90 (80–100) .03 30 90 (80–100) 10 90 (80–100) .91
Prerefresher training 2 39 90 (80–100) 15 85 (75–85) 42 70 (60–85) <.001 31 75 (65–85) 11 65 (55–75) .13
Postrefresher training 2 36 100 (95–100) 13 85 (85–95) 44 82.5 (72.5–95) <.001 31 90 (75–95) 13 80 (70–90) .46
Online MCQ 2 42 100 (95–100) 14 65 (60–80) 43 85 (65–95) <.001 33 85 (60–95) 10 87.5 (80–95) .59
Abbreviations: IQR, interquartile range; MCQ, multiple-choice question; PERCH, Pneumonia Etiology Research for Child Health.
aP value obtained by Kruskal-Wallis test.
Table 5. Agreement With Principal Trainer and Interobserver Agreement for Select Clinical Signs
Agreement With Trainera Interobserver Agreement
Clinical Sign No. of Videos Percentage Agreement With Trainer, Median (IQR) AC1b κb
LCWI 10 89.1 (85.4–95.8) 0.62 0.62
Head nodding 5 99.0 (95.8–99.0) 0.88 0.87
Deep breathing 5 92.7 (92.7–99.0) 0.82 0.80
Central cyanosis 5 90.2 (75.8–94.6) 0.54 0.54
Nasal flaring 5 95.8 (93.8–99.0) 0.79 0.68
Alert child 5 94.8 (83.3–97.9) 0.62 0.62
Abbreviations: IQR, interquartile range; LCWI, lower chest wall indrawing.
aOne hundred ten staff members who assessed Pneumonia Etiology Research for Child Health (PERCH) cases and/controls were available for the video quiz. Ninety-six (87%) staff partic-
ipated in the video quiz (14 missing values).
bFor both the AC1 and κ statistic, a value of 0 indicates no agreement beyond chance, while a value of 1 denotes perfect agreement. Values of ≤0.40 are generally indicative of poor agree-
ment, 0.41–0.60 moderate agreement, 0.61–0.80 substantial agreement, and >0.80 excellent agreement.
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Clinical video has been shown previously to be an effective 
way of testing agreement between clinicians on the presence or 
absence of clinical signs [6], despite the obvious difference from 
the “real-life” clinical situation, in which a clinician’s judgement 
is affected by information other than an isolated clinical sign. 
The same study showed that health workers of different cadres 
and varying levels of clinical experience could correctly identify 
clinical signs from video recordings for which there was high 
proportionate agreement between experts [6]. Clinical signs 
are not, however, always clear-cut in real-life. To this end, the 
PERCH video quiz included a random selection (approximately 
20%) of “gray” cases—namely, those in which a clinical sign 
(eg, LCWI) was present but subtle, making it genuinely diffi-
cult to decide on its presence or absence. Despite this, percent-
age agreement between staff and the trainer was ≥89% for all 6 
clinical signs in the quiz, while interobserver agreement (agree-
ment between participants) varied from “moderate” for central 
cyanosis, a clinical sign which is easily missed in African chil-
dren and which is difficult to photograph or film successfully, 
to “substantial” or “excellent” for the other clinical signs. Good-
quality clinical video clips are a valuable and scarce resource, 
and we hope that the video clips available on the PERCH clin-
ical standardization training website (www.perchtraining.org) 
will be useful for other clinical researchers.
Although the PERCH clinical standardization program 
successfully attained its objectives, a number of useful lessons 
have been learned. It would have been informative to evaluate 
staff knowledge and skills prior to the initial training course, as 
this would have provided a useful baseline comparator for the 
subsequent MCQ scores. The improvement in MCQ scores with 
refresher training suggests that it would have been valuable to 
have had more regular refresher training courses at each site, 
coordinated by local site trainers. Limited availability of personal 
computers and slow internet speeds reduced the utility of the 
training website at several of the study sites. These shortcomings 
are not shared by mobile phone technology, which could provide 
a useful alternative platform for training and evaluation. It took 
time to obtain a sufficient number of good-quality video clips of 
relevant clinical signs, and consequently the video quiz took place 
during the final 4 months of enrollment, by which time many of 
the original PERCH staff had left the study. It would have been 
preferable to organize the quiz at the start of enrollment, and 
repeat it during the second year. Although the checklist evalua-
tions of practical skills were useful training and evaluation tools, 
they were time-consuming and were consequently performed 
on approximately 60% of the relevant study staff. High rates 
of staff turnover emphasized the importance of establishing a 
robust system for training new staff outside of the regular train-
ing schedule. Turnover was lowest among clinical officers, which 
may reflect their longer-term clinical attachments.
There is increasing recognition that public health policy should 
be based on data that are globally representative. Enhanced con-
nectivity, the widespread availability of powerful computing, sta-
tistical and data management tools, and the advent of funders 
willing to pay for large networked studies have increased the 
feasibility of conducting large, multicountry research studies. 
Ensuring that the clinical and laboratory data obtained during the 
course of such studies are robust, standardized, and comparable 
Figure 2. Staff retention during the course of the Pneumonia Etiology Research for Child Health (PERCH) study, by site. Kaplan-Meier graph displaying the proportion of 
staff attending the initial baseline training (N = 137) who remained with the study; analysis includes all staff members regardless of whether or not they enrolled study 
participants. Drops represent staff members leaving the study over time. The table beneath the graph indicates the number of staff members who remained in the study over 
time. Abbreviations: BAN, Bangladesh; GAM, The Gambia; KEN, Kenya; MAL, Mali; SAF, South Africa; THA, Thailand; ZAM, Zambia.
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is of paramount importance. The results of the PERCH clinical 
standardization program give us confidence that any etiological or 
clinical differences observed across the study sites are true differ-
ences, and not attributable to differences in application of the clin-
ical case definition or differences in techniques used for clinical 
measurements or specimen collection. We hope that the methods, 
results, and lessons learned from the PERCH clinical standardi-
zation program will usefully inform other researchers embarking 
on large-scale clinical or epidemiological studies of pneumonia or 
other major causes of childhood morbidity and mortality.
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